Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2007
06/14/2007WO2007067992A2 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
06/14/2007WO2007067984A2 Neutralizing antibodies against primate psgl-1 and uses therefor
06/14/2007WO2007067983A2 Sulfotyrosine specific antibodies and uses therefor
06/14/2007WO2007067596A2 Methods and compositions for needleless delivery of antibodies
06/14/2007WO2007067046A1 Means and methods for influencing the stability of antibody producing cells
06/14/2007WO2007067032A1 Means and methods for influencing the stability of cells
06/14/2007WO2007066823A1 Antibody against connective tissue growth factor or composition containing the same
06/14/2007WO2007066698A1 Genetically recombinant anti-perp antibody
06/14/2007WO2007066423A1 Tumor antigen peptide derived from amacr
06/14/2007WO2007066109A1 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
06/14/2007WO2007066106A1 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor
06/14/2007WO2007066082A1 Antibody molecules having specificity for human il-6
06/14/2007WO2007034210A3 Deglycosylated anti-muc-1 antibodies and uses thereof
06/14/2007WO2007020357A3 Method for carrying out homogeneous phase detection, in particular, for detecting the progesterone in the milk of a mammal and corresponding kit
06/14/2007WO2007014253A3 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
06/14/2007WO2007002525A3 Tomoregulin antibodies and uses thereof
06/14/2007WO2006123246A3 Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors
06/14/2007WO2006082515A3 Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof
06/14/2007WO2006073982A3 Bispecific molecule comprising ligands for cell-surface protein and t-cell surface protein
06/14/2007WO2006065533A3 Engineered antibodies and immunoconjugates
06/14/2007WO2006039418A3 Human monoclonal antibodies to fc gamma receptor ii (cd32)
06/14/2007WO2005016236A3 Antibodies that immunospecifically bind to trail receptors
06/14/2007WO2003012126A3 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
06/14/2007US20070136832 Novel lipoxygenase proteins and polynucleotides encoding the same
06/14/2007US20070136829 Novel type-1 cytokine receptor glm-r
06/14/2007US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders
06/14/2007US20070136826 Anti-mouse CD20 antibodies and uses thereof
06/14/2007US20070135998 Altered antibodies having improved antigen-binding affinity
06/14/2007US20070135621 Therapeutic products with enhance ability to immunomodulate cell functions
06/14/2007US20070135620 Fc variants with altered binding to FcRn
06/14/2007US20070135361 Method of diagnosing alzheimer's disease by detection of chlamydia pneumoniae
06/14/2007US20070135360 Determining whether cerebralspinal fluid sample contains Chlamydia pneumoniae
06/14/2007US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders
06/14/2007US20070135344 Novel growth factor and a genetic sequence encoding same
06/14/2007US20070135337 Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
06/14/2007US20070134759 Process for producing antibody composition by using rna inhibiting the function of alpha1,6-fucosyltransferase
06/14/2007US20070134749 Protein tyrosine kinase substrate lat and its use in the identification of (ANT)agonists of the kinase
06/14/2007US20070134746 Using concentration of iron regulating polypeptide to detect blood disorders; immunoassay
06/14/2007US20070134745 Using cytokine receptor-16 expression as evaluative tool in diagnosis of cell proliferative disorders
06/14/2007US20070134744 Epothilone resistant cell lines
06/14/2007US20070134742 Diagnostic reagent for uterine adenocarcinoma and method of detecting adenocarcinoma cells
06/14/2007US20070134734 Novel screening method of indicator substance
06/14/2007US20070134727 Antibodies to cytokine receptor
06/14/2007US20070134724 Phosphorylation of tau by abl
06/14/2007US20070134704 Expression vector comprising nucleotide sequences coding fluorescent neurofilament protein (NFP) for diagnostic imaging tool in molecular genetics
06/14/2007US20070134703 Chromophores/fluorophores and methods for using the same
06/14/2007US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
06/14/2007US20070134258 Gasp1: a follistatin domain containing protein
06/14/2007US20070134256 Chimpanzee Fab antibodies against DENV-4; isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith
06/14/2007US20070134254 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy
06/14/2007US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
06/14/2007US20070134252 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
06/14/2007US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3
06/14/2007US20070134247 Prevention of brain inflammation as a result of induced autoimmune response
06/14/2007US20070134246 Antibodies to TGF-BETA
06/14/2007US20070134245 Rankl antibody-PTH/PTHrP chimeric molecules
06/14/2007US20070134243 Antibody drug conjugates and methods
06/14/2007US20070134242 Mesothelioma therapeutic agent
06/14/2007US20070134241 Humanized anti-CD3 specific antibodies
06/14/2007US20070134240 Use of a CD28 binding substance for making a pharmaceutical composition
06/14/2007US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
06/14/2007US20070134237 Human cytokine receptor
06/14/2007US20070134236 Humanized antibodies against monocyte chemotactric proteins
06/14/2007US20070134235 Endothelialization of vascular surfaces
06/14/2007US20070134234 Immunomodulatory compositions and uses therefor
06/14/2007US20070134233 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies
06/14/2007US20070134228 Immunoaffinity purification
06/14/2007US20070134162 Labeling reactant
06/14/2007DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy
06/14/2007CA2638902A1 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 antibodies
06/14/2007CA2633157A1 Means and methods for influencing the stability of antibody producing cells
06/14/2007CA2632628A1 Antibody molecules having specificity for human il-6
06/14/2007CA2632552A1 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use
06/14/2007CA2632517A1 Methods for cyclic nucleotide determination
06/14/2007CA2632424A1 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
06/14/2007CA2632419A1 Genetically recombinant anti-perp antibody
06/14/2007CA2632417A1 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor
06/14/2007CA2631981A1 Methods and compositions for needleless delivery of binding partners
06/14/2007CA2631952A1 Methods and compositions for needleless delivery of antibodies
06/14/2007CA2630483A1 Human monoclonal antibodies to o8e
06/13/2007EP1795598A1 Novel peptides
06/13/2007EP1795595A1 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
06/13/2007EP1795592A2 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3
06/13/2007EP1795203A2 Fhit proteins and nucleic acids and methods based thereon
06/13/2007EP1794588A2 Methods and compositions for measuring canine bnp and uses thereof
06/13/2007EP1794586A1 Monoclonal antibodies to progastrin
06/13/2007EP1794322A2 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk
06/13/2007EP1794304A2 Plant cells and plants with increased tolerance to environmental stress
06/13/2007EP1794188A1 Dna replication modulating peptides, nucleic acids encoding them, and their use in pharmaceutical compositions
06/13/2007EP1794187A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor
06/13/2007EP1794185A1 Piscirickettsia salmonis antigens and use thereof
06/13/2007EP1793857A2 Combination therapy with anti-ctla4 and anti-4-1bb antibodies
06/13/2007EP1793856A2 Methods and compositions for treating allergic inflammation
06/13/2007EP1470146B1 Antibodies against the muc18 antigen
06/13/2007EP1444268B1 Bispecific anti-cd28 antibody molecule
06/13/2007EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2007EP1302542B1 Novel physiologically active peptide and use thereof
06/13/2007EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
06/13/2007EP1235862B1 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralization antibodies
06/13/2007EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 1494